OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: University of Utah

1 Projects | 1 Researchers | $500,000 Invested

2021

University of Utah

Qinwen Mao, MD, PhD

Plasma pathologic TDP-43 as a biomarker for FTLD-TDP

  • Funding Amount: $500,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Target: TDP-43
  • Status: Active